Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders
ConclusionsThe results of our review suggest that incorporating productivity cost elements may positively affect cost-effectiveness outcomes in evaluations of therapeutics for immune-mediated disorders. Our work highlights the continued need for clarity when reporting how CEAs and CUAs in this disease area are conducted, in order to better inform healthcare decision-making.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Crohn's Disease | Databases & Libraries | Drugs & Pharmacology | Fibromyalgia | Hives | Inflammatory Bowel Disease | Lupus | Psoriasis | Rheumatoid Arthritis | Rheumatology | Statistics | Study | Ulcerative Colitis | Unemployment